title: Changes in selenoprotein P in substantia nigra and putamen in Parkinson's disease.
abstract: Oxidative stress and oxidized dopamine contribute to the degeneration of the nigrostriatal pathway in Parkinson's disease (PD). Selenoproteins are a family of proteins containing the element selenium in the form of the amino acid selenocysteine, and many of these proteins have antioxidant functions. We recently reported changes in expression of the selenoprotein, phospholipid hydroperoxide glutathione peroxidase GPX4 and its co-localization with neuromelanin in PD brain. To further understand the changes in GPX4 in PD, we examine here the expression of the selenium transport protein selenoprotein P (Sepp1) in postmortem Parkinson's brain tissue. Sepp1 in midbrain was expressed in neurons of the substantia nigra (SN), and expression was concentrated within the centers of Lewy bodies, the pathological hallmark of PD. As with GPX4, Sepp1 expression was significantly reduced in SN from PD subjects compared with controls, but increased relative to cell density. In putamen, Sepp1 was found in cell bodies and in dopaminergic axons and terminals, although levels of Sepp1 were not altered in PD subjects compared to controls. Expression levels of Sepp1 and GPX4 correlated strongly in the putamen of control subjects but not in the putamen of PD subjects. These findings indicate a role for Sepp1 in the nigrostriatal pathway, and suggest that local release of Sepp1 in striatum may be important for signaling and/or synthesis of other selenoproteins such as GPX4.
authors.affiliation: Cell and Molecular Biology Department, John A. Burns School of Medicine, University of Hawaii, HI 96813, USA. fb@hawaii.edu
authors.forename: Frederick P
authors.initials: FP
authors.lastname: Bellinger
authors.forename: Arjun V
authors.initials: AV
authors.lastname: Raman
authors.forename: Rachel H
authors.initials: RH
authors.lastname: Rueli
authors.forename: Miyoko T
authors.initials: MT
authors.lastname: Bellinger
authors.forename: Andrea S
authors.initials: AS
authors.lastname: Dewing
authors.forename: Lucia A
authors.initials: LA
authors.lastname: Seale
authors.forename: Marilou A
authors.initials: MA
authors.lastname: Andres
authors.forename: Jane H
authors.initials: JH
authors.lastname: Uyehara-Lock
authors.forename: Lon R
authors.initials: LR
authors.lastname: White
authors.forename: G Webster
authors.initials: GW
authors.lastname: Ross
authors.forename: Marla J
authors.initials: MJ
authors.lastname: Berry
mesh_terms: D000369:Aged, 80 and over; D000704:Analysis of Variance; D001213:Asian; D005979:Glutathione Peroxidase / Q000378:metabolism; D006254:Hawaii; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000473:pathology*; D000080662:Phospholipid Hydroperoxide Glutathione Peroxidase; D011699:Putamen / Q000378:metabolism*; D051149:Selenoprotein P / Q000378:metabolism*; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000378:metabolism*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism; D051844:alpha-Synuclein / Q000378:metabolism
chemical_list: D051149:Selenoprotein P; D051844:alpha-Synuclein; D000080662:Phospholipid Hydroperoxide Glutathione Peroxidase; D005979:Glutathione Peroxidase; D014446:Tyrosine 3-Monooxygenase